PMC5840851_01
Fig. 1 shows the position of the intracardiac pacemaker device in the right ventricle on a standard chest X-ray one day after implantation of the device.
gr1.jpg
PMC5840851_01_gr1.jpg
fig1
The leadless pacemaker was implanted three months prior to presentation for bradycardia in the setting of persistent atrial fibrillation (persAF) (Fig. 1).
12-lead-ECG recordings prior to (a) and immediately after (b) external CV as well as intracardiac electrograms during testing of pacing (c) and sensing (d) functions immediately after CV are shown.
gr2.jpg
PMC5840851_01_gr2.jpg
fig2
After CV, a device interrogation and a 12-lead-ECG were repeated (Fig. 2a-d).